scholarly journals An exploration of the bone health of older adults with an intellectual disability in Ireland

2016 ◽  
Vol 61 (2) ◽  
pp. 99-114 ◽  
Author(s):  
E. A. Burke ◽  
P. McCallion ◽  
R. Carroll ◽  
J. B. Walsh ◽  
M. McCarron
Keyword(s):  
Older Adults ◽  
Intellectual Disability ◽  
Bone Health

scholarly journals The relationship between antiepileptic drug load and challenging behaviors in older adults with intellectual disability and epilepsy

2021 ◽  
Vol 122 ◽  
pp. 108191
Author(s):  
Rosemary Monaghan ◽  
Máire O'Dwyer ◽  
Retha Luus ◽  
Niamh Mulryan ◽  
Philip McCallion ◽  
...  
Keyword(s):  
Older Adults ◽  
Intellectual Disability ◽  
Antiepileptic Drug ◽  
Challenging Behaviors ◽  
Drug Load ◽  
The Relationship

scholarly journals The Effects of an Online Theory-Based Bone Health Program for Older Adults

2015 ◽  
Vol 36 (9) ◽  
pp. 1117-1144 ◽  
Author(s):  
Eun-Shim Nahm ◽  
Barbara Resnick ◽  
Clayton Brown ◽  
Shijun Zhu ◽  
Jay Magaziner ◽  
...  
Keyword(s):  
Older Adults ◽  
Bone Health ◽  
Calcium Intake ◽  
Health Program ◽  
Outcome Expectations ◽  
Control Group ◽  
Discussion Boards ◽  
Learning Modules ◽  
Osteoporosis Knowledge ◽  
Efficacy Outcome

An estimated 10 million Americans age 50 and older have osteoporosis, and many experience associated fractures. Although several interventions have been shown to be effective in preventing osteoporosis, their impact on bone health among older adults was limited. The aim of this study was, therefore, to examine the effects of a theory-based online bone health program (Bone Power program) for a large number of older adults. The 8-week program included learning modules, discussion boards, and other resources. Participants ( N = 866; M age = 62.5 years) were recruited online and randomized into a Bone Power or control group. At the end of the intervention, the Bone Power group showed significantly greater improvement over the control group in osteoporosis knowledge, self-efficacy/outcome expectations for calcium intake and exercise, and calcium intake and exercise behaviors. This study’s findings suggest that online health programs can be effective in improving older adults’ knowledge, beliefs, and health behaviors.

Epidemiology of Epilepsy in Older Adults With an Intellectual Disability in Ireland: Associations and Service Implications

2014 ◽  
Vol 119 (3) ◽  
pp. 253-260 ◽  
Author(s):  
Mary McCarron ◽  
Marie O'Dwyer ◽  
Eilish Burke ◽  
Eimear McGlinchey ◽  
Philip McCallion
Keyword(s):  
Older Adults ◽  
Intellectual Disability ◽  
Longitudinal Study ◽  
Refractory Epilepsy ◽  
Demographic Variables ◽  
Health Conditions ◽  
Community Settings ◽  
Morbid Conditions

Abstract There are limited studies on the prevalence of epilepsy and co-morbid conditions in older adults with an ID. To begin to address this prevalence of epilepsy was estimated for participants in the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing. Associations with demographic variables and co morbid health conditions were examined. It was found that prevalence was high (30.7%); but declined as people aged. Those with epilepsy were less likely to live with family, independently or in community settings, rates of refractory epilepsy were high and, despite medication over half of those with epilepsy still reported experiencing seizures. Given these findings, people with ID and their careers have considerable needs for information about epilepsy management, and for support from specialist ID and epilepsy services.

scholarly journals The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study

2018 ◽  
Vol 26 (7) ◽  
pp. 1012-1021
Author(s):  
Hadiah AlMutairi ◽  
Máire O'Dwyer ◽  
Mary McCarron ◽  
Philip McCallion ◽  
Martin C. Henman
Keyword(s):  
Older Adults ◽  
Intellectual Disability ◽  
Observational Study ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Cross Sectional

scholarly journals Older adults with intellectual disability

2012 ◽  
Vol 25 (5) ◽  
pp. 359-364 ◽  
Author(s):  
Amanda Sinai ◽  
Ingrid Bohnen ◽  
Andre Strydom
Keyword(s):  
Older Adults ◽  
Intellectual Disability

scholarly journals 298ASSOCIATIONS BETWEEN MEDICATION USE AND FALLS AMONG OLDER ADULTS WITH INTELLECTUAL DISABILITY IN IRELAND

2016 ◽  
Vol 45 (suppl 2) ◽  
pp. ii1.51-ii12
Author(s):  
Sinead Foran ◽  
Maire O Dwyer ◽  
Mary McCarron ◽  
Martin Henman ◽  
Philip McCallion
Keyword(s):  
Older Adults ◽  
Intellectual Disability ◽  
Medication Use

scholarly journals Causes of Mortality in Older People With Intellectual Disability: Results From the HA-ID Study

2018 ◽  
Vol 123 (1) ◽  
pp. 61-71 ◽  
Author(s):  
Alyt Oppewal ◽  
Josje D. Schoufour ◽  
Hanne J.K. van der Maarl ◽  
Heleen M. Evenhuis ◽  
Thessa I.M. Hilgenkamp ◽  
...  
Keyword(s):  
Older Adults ◽  
Intellectual Disability ◽  
Cause Of Death ◽  
Causes Of Death ◽  
Circulatory System ◽  
Bacterial Diseases ◽  
Specific Mortality ◽  
Causes Of Mortality ◽  
Insight Into

Abstract We aim to provide insight into the cause-specific mortality of older adults with intellectual disability (ID), with and without Down syndrome (DS), and compare this to the general population. Immediate and primary cause of death were collected through medical files of 1,050 older adults with ID, 5 years after the start of the Healthy Ageing and Intellectual Disabilities (HA-ID) study. During the follow-up period, 207 (19.7%) participants died, of whom 54 (26.1%) had DS. Respiratory failure was the most common immediate cause of death (43.4%), followed by dehydration/malnutrition (20.8%), and cardiovascular diseases (9.4%). In adults with DS, the most common cause was respiratory disease (73.3%), infectious and bacterial diseases (4.4%), and diseases of the digestive system (4.4%). Diseases of the respiratory system also formed the largest group of primary causes of death (32.1%; 80.4% was due to pneumonia), followed by neoplasms (17.6%), and diseases of the circulatory system (8.2%). In adults with DS, the main primary cause was also respiratory diseases (51.1%), followed by dementia (22.2%).

scholarly journals Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland

2020 ◽  
Author(s):  
Mary E. Walsh ◽  
Tom Fahey ◽  
Frank Moriarty
Keyword(s):  
Older Adults ◽  
Primary Care ◽  
Vitamin D ◽  
Fracture Risk ◽  
Bone Health ◽  
Pharmacological Treatment ◽  
Age Group ◽  
Oral Bisphosphonates ◽  
Factors Associated ◽  
Increase Fracture Risk

ABSTRACTPurposeGaps in pharmacological treatment for osteoporosis can reduce effectiveness. This study aimed to estimate persistence rates for oral bisphosphonates and denosumab in older primary care patients and identify factors associated with discontinuation.MethodsOlder patients newly prescribed oral bisphosphonates or denosumab between 2012 and 2017 were identified from 44 general practices (GP) in Ireland. Persistence without a coverage gap of >90 days was calculated for both medications from therapy initiation. Factors associated with time to discontinuation were explored using Cox regression analysis. Exposures included age-group, osteoporosis diagnosis, fracture history, calcium/vitamin D prescription, number of other medications, health cover, dosing frequency (bisphosphonates) and previous bone-health medication (denosumab).ResultsOf 41,901 patients, n=1,569 newly initiated on oral bisphosphonates and n=1,615 on denosumab. Two-year persistence was 49.4% for oral bisphosphonates and 53.8% for denosumab and <10% were switched to other medication. Having state-funded health cover was associated with a lower hazard of discontinuation for both oral bisphosphonates (HR=0.49, 95%CI=0.36-0.66, p<0.01) and denosumab (HR=0.71, 95%CI=0.57-0.89, p<0.01). Older age-group, number of medications and calcium/vitamin D prescription were also associated with better bisphosphonate persistence while having osteoporosis diagnosed was associated with better denosumab persistence.ConclusionPersistence for osteoporosis medications is sub-optimal. Of concern, few patients are switched to other bone-health treatments when denosumab is stopped which could increase fracture risk. Free access to GP services and medications may have resulted in better medication persistence in this cohort. Future research should explore prescribing choices in primary-care osteoporosis management and evaluate cost-effectiveness of interventions for improving persistence.SUMMARYGaps in pharmacological treatment for osteoporosis can reduce its effectiveness. This study found approximately half of older adults in primary care newly initiated on bisphosphonates or denosumab were still taking these after 2 years. Abrupt discontinuation of denosumab without switching to an alternative is concerning due to increased fracture risk.

Sign in / Sign up

Export Citation Format

Share Document